Skip to NavigationSkip to content

News

researchers from the University of Sydney have found that as much as 29% of trials in breast cancer did not adequately establish a control arm.
The measles virus has been eliminated from the UK for the first time in the country’s history, according to the WHO. Qualification for eradication is...
Roche's Tecentriq secures approval from the European Commission to be used in the treatment of metastatic non-small cell lung cancer (NSCLC) and...
A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test that could potentially save millions...
EMA has warned that, at best, it expects to retain only 73% of its staff, leading to approval delays and, at worst, limited drug availability as its...
Facilities on Puerto Rico are responsible for manufacturing a large number of medicines sold worldwide, and the devastation wrought by Hurricane...
Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. On the release of Phase 3 results, it appears...
Intellipharma has been knocked back by the FDA for its product, known now as Oxycodone ER, under the proviso that it return with further data about...
New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic minorities...
The operation saw the arrest of over 400 individuals and the seizure of more than $51 million of illegal, and potentially dangerous, medicines.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches